Clinical Trial Update: AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating AK112 in combination with an AP regimen as neoadjuvant therapy for operable locally advanced head and neck squamous cell carcinoma; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• AK112

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Neoadjuvant Therapy of Operable Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING